MiR | Target genes and functions in obesity | Target genes and functions in breast cancer | References |
---|---|---|---|
21 | TGF-βR2 inhibition PTEN inhibition, reduced AP-1 | PTEN inhibition, PI3K/Akt activation | |
24-3p | Inhibit SR-B1 that regulate cholesterol uptake, increase HMGCR, DHCR24 and SREBP2 | Inhibit p27Kip1, inhibit Bim, cell cycle proliferation | |
155 | Upregulated in inflammation targets PPAR-γ | Downregulate SOC-1, upregulate MMP6 | |
210 | Inhibit Wnt signaling, increase adipogenesis | E-cadherin, HIF1-α, metastasis, proliferation | |
221/222 | Erα, GLUT4, reduced insulin stimulation of glucose uptake | Inhibit PTEN and p27(Kip), activate Akt, ER-alpha, inhibit IncRNA GAS5 down regulate MYC, increase proliferation, cell cycle, survival | |
3184-3p | FOXP4–NOTCH induced EMT pathway proliferation of MABC cells | [67] | |
let-7 | Inhibit HMGA2, inhibit preadipocyte proliferation | Inhibit HMGA2, MYC, JAK-STAT-3, Caspase-3, RAS, CCND2, Erα decrease invasion tumor suppressor function | |
26b | Inhibit PTEN/PI3K/AKT pathway to modulate insulin sensitivity | Serpin B2, anti-metastasis and anti-invasion | |
27b | Control lipid metabolisms inhibit PPAR-γ | FOXO1, ST14 BAK SPRY2 TMEM170B CBLB/GRB2 apoptosis, cell-cycle checkpoint | |
30a | Suppression of STAT1 to limit Interferon γ-signaling | Cyclin E2; anti proliferative G1, cell cycle arrest | |
181c-3p | PPARα; reduced inhibition of PPARα, BC proliferation | [67] | |
143-3p | PPAR-γ, AP2, leptin pathway, ERK5 | DNMT3A, PTEN hypermethylation, increase TNFRS F10c methylation, KRAS, AKT1, BCL2 | [44] |
148a-3p | inhibit DNMT1 which is correlated with obesity | WNT-1, β-catenin, MMP-7, TCF-4, BCl-2, caspases, anti metastasis, anti invasion by regulating Wnt/β-catenin signaling pathway | |
302b | Maintain SOX2 and c-Myc by targeting repressor of c-Myc | Target RUNX2, that activate PI3K/AKT signaling and regulate proliferation | |
34a | Inhibit macrophage M2 induced adipose inflammation | Inhibit BCL2, CCND1, MYC, E2F3, CDK6, SIRT1 anti-apoptosis |